MICHELLE SALISBURY: Open Payments
NPI 1730502683 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$759 in 35 payments from 12 companies in 2025. Trend: 2023 $864 · 2024 $62 · 2025 $759
Food & beverage: $591Education: $168
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 17 | $176 |
| Astellas Pharma US Inc | 2 | $168 |
| Endo USA, Inc. | 4 | $158 |
| UROGEN PHARMA, INC. | 3 | $84 |
| ABBVIE INC. | 2 | $28 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $27 |
| DENTSPLY IH AB | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| Teleflex LLC | 1 | $20 |
| Ferring Pharmaceuticals Inc. | 1 | $17 |
Products named: GEMTESA, XIAFLEX, JELMYTO, AVEED, LUPRON DEPOT, PYLARIFY, LOFRIC, PLUVICTO.
Industry payments across IN — which companies pay providers there.
